Results 181 to 190 of about 106,270 (318)
Statistical Merits of U Control Chart when Using VSSI Sampling Policy [PDF]
, 2020 Din Mohammad Imani, Mohsen Shojaie
openalex +1 more source
Molecular Oncology, EarlyView.We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Revista Brasileira de Cineantropometria e Desempenho Humano, 2013 In long distance swimming competitions, the optimal pacing strategy is not well established. The objective of this study was to characterize the pacing strategy adopted by international level athletes in 800-m (female) and 1500-m (male) crawl swimming ...
Mayara Vieira Damasceno +6 more
doaj
Statistical Methods for Accurately Determining Criticality Code Bias (U)
, 2023 K. D. Kimball, E. F. Trumble
openalex +1 more source
Molecular Oncology, EarlyView.Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Highly robust causal semiparametric U-statistic with applications in biomedical studies. [PDF]
Int J BiostatYin A, Yuan A, Tan MT.
europepmc +1 more source
Next‐generation proteomics improves lung cancer risk prediction
Molecular Oncology, EarlyView.This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
Molecular Oncology, EarlyView.WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
On the Edgeworth Expansion and the Bootstrap Approximation for a Studentized $U$-Statistic [PDF]
, 1991 Roelof Helmers
openalex +1 more source